Results 251 to 260 of about 1,994,731 (278)
Some of the next articles are maybe not open access.
Ranking of High‐Affinity Ligands by NMR Spectroscopy
Angewandte Chemie International Edition, 2009Xiaolu, Zhang +3 more
openaire +2 more sources
RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis
Nature, 2010E. González-Suárez +8 more
semanticscholar +1 more source
Denosumab, a RANK Ligand Inhibitor, for Postmenopausal Women with Osteoporosis
The Annals of Pharmacotherapy, 2012Emily E Sutton, D. Riche
semanticscholar +1 more source
[Inhibition of RANK ligand to treat bone metastases].
Bulletin du cancer, 2014Bone is the most common metastatic site. The skeleton is also the preferential initial metastatic site in breast and prostate carcinomas. Objective complications of bone metastases are named « skeletal-related events » (SREs) and generally include the need for radiotherapy on bone, surgery to bone, pathologic fracture and spinal cord compression ...
openaire +1 more source
Recent Progress in the Management of Advanced Renal Cell Carcinoma
Ca-A Cancer Journal for Clinicians, 2007Brian I Rini
exaly
The role of ligand efficiency metrics in drug discovery
Nature Reviews Drug Discovery, 2014Andrew L Hopkins +2 more
exaly

